Menu

indus biotech

Science • Safety • efficacy

THE INDUS ADVANTAGE

Consumer healthcare products of today belong to the continuum that addresses preservation of health, performance enhancement, risk reduction for disease susceptibility and therapeutics. Indus Biotech's consumer healthcare products are discovered and developed from food chain raw materials. They meet with regulation standards in the USA and are flexible enough to be positioned into the following categories:

  • Dietary Supplements
  • Medical Foods
  • Botanical Drugs

Indus Biotech's products can be customized to meet regulatory standards as per the following procedures and timelines:

Targeted Timeline to Market

Targeted Monetisation Timeline

Positioning and flexibility of products

Discovery and development of consumer healthcare products at Indus Biotech enables flexibility in positioning into various regulatory environments globally. This development paradigm offers a unique advantage in investing in development of products according to their regulatory potential.

Investment - Category Spectrum

Targeted Monetisation Timeline

Pipeline

Ready-to-launch products

Products Indication Target Preclinical Research
IN-VIVO
Preclinical Research
TOXICOLOGY
Preclinical Research
IN-VITRO
Studies for Early Patient Data
Sugaheal Diabetes Mellitus Multitarget
INDUS810 Prediabetes and Metabolic syndrome Multitarget
INSIX RA Bone and Joint health, Inflammation, Rheumatoid arthritis PD1
IND02 Chemo Adjuvant Chemotherapy side effects (e.g. Cachexia & Alopecia) Cytokine and TNF inhibition
IND02-AR Seasonal Allergic Rhinitis Mast cell de-granulation
INDUS860-Migraine Migraine with or without anxiety 5HT1A receptor
Syneuro Delaying Progression of Parkinson's Disease α-synuclein Aggregation
IND02-HIV HIV/AIDS and co-infection with TB or HCV Gp120/TIM3

Products under development

Products Indication Target Preclinical Research
IN-VIVO
Preclinical Research
TOXICOLOGY
Preclinical Research
IN-VITRO
Studies for Early Patient Data
Sugaheal Variant(IBIS) Diabetes complication-Neuropathy Multitarget
Sugaheal Variant(IBHB) Diabetes complication-Nephropathy Multitarget
INDUS860-Depression Depression and stress related CNS diseases 5HT1A receptor
IND08 Heart diseases (hypertrophy and chemo induced cardiotoxicity) Studies ongoing
IBHB Urolithiasis (Kidney stone) ---
INDUS903 Glomerulonephritis/ Tubular Interstitial nephritis (TIN) PD1
INDUS905 Ulcerative colitis (Inflammatory Bowel disease) and Peptic Ulcer smad (TGFβ independent) and H. pylori
INDUS815C Huntington disease SIRT2 inhibition
INDUS820 Diabetic foot/Pressure ulcer Studies ongoing
-

"Effects Of Fenugreek, Cinnamon, & Curcumin Supplementation On Post Workout Il6 And..."...

ACSM

"Ameliorative effects of a polyphenolic fraction of Cinnamomum zeylanicum L. bark in animal m...

NCBI

"Neurobehavioral assessment of hydroalcoholic extract of Trigonella foenum-graecum seeds in r...

NCBI

MORE...